| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $30.0M | +47.5% |
| SG&A Expense | $11.7M | +6.7% |
| Operating Income | -$41.7M | +49.1% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$39.2M | +52.3% |
| Income Tax | $0 | — |
| Net Income | -$39.2M | +52.3% |
| EPS (Basic) | -$0.37 | +71.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.9M | -75.8% |
| Short-term Investments | $151.7M | — |
| Current Assets | $194.8M | +32.4% |
| Total Assets | $199.6M | +29.8% |
| Current Liabilities | $16.2M | +52.1% |
| Total Liabilities | $18.0M | +31.6% |
| Stockholders' Equity | $181.6M | +29.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.1M | -73.5% |
| Capital Expenditures | $212K | -86.5% |
| Investing Cash Flow | -$151.2M | -8442.4% |
| Financing Cash Flow | $75.8M | -36.1% |
| Free Cash Flow | -$34.3M | -61.7% |